FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Douglas Mapel

Research Profile

Disorders

Pulmonary Disease, Chronic Obstructive

Geographic Areas

Concepts & Ideas

Procedures

Activities & Behaviors

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Douglas W Mapel; Andrew Overhiser; Melissa Roberts; Andrew Mason
The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.
Douglas W Mapel; Jenõ P Marton
Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD.
Douglas W Mapel; Melissa H Roberts
New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Douglas Mapel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Douglas W Mapel; Andrew Overhiser; Melissa Roberts; Andrew Mason
The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.
Helicobacter 2013;18(1):54-65.
2013: Douglas W Mapel; Jenõ P Marton
Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD.
International journal of chronic obstructive pulmonary disease 2013;8():127-34.
2012: Douglas W Mapel; Melissa H Roberts
New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.
PharmacoEconomics 2012;30(10):869-85.
2012: Melissa H Roberts; Douglas W Mapel
Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults.
American journal of epidemiology 2012;176(2):127-34.
2012: Barry Make; Jenö P Marton; Ryne Paulose-Ram; Michael P Dutro; Douglas W Mapel
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients.
International journal of chronic obstructive pulmonary disease 2012;7():1-9.
2011: Matthew L Mintz; Barbara P Yawn; David M Mannino; James F Donohue; Nicola A Hanania; Catherine A Grellet; Alicia W Gilsenan; Lori D McLeod; Anand A Dalal; Ibrahim H Raphiou; Barbara A Prillaman; Glenn D Crater; Michael J Cicale; Douglas W Mapel
Prevalence of airway obstruction assessed by lung function questionnaire.
Mayo Clinic proceedings. Mayo Clinic 2011;86(5):375-81.
2011: Anand A Dalal; Manan Shah; Anna O D'Souza; Douglas W Mapel
COPD-related healthcare utilization and costs after discharge from a hospitalization or emergency department visit on a regimen of fluticasone propionate-salmeterol combination versus other maintenance therapies.
The American journal of managed care 2011;17(3):e55-65.
2011: Douglas W Mapel; Hans Petersen; Christopher M Blanchette; Anand A Dalal; Gary T Ferguson
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.
International journal of chronic obstructive pulmonary disease 2011;6():573-81.
2011: Douglas W Mapel; Michael P Dutro; Jeno P Marton; Kimberly Woodruff; Barry Make
Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data.
BMC health services research 2011;11():43.
2011: Christopher M Blanchette; Melissa H Roberts; Hans Petersen; Anand A Dalal; Douglas W Mapel
Economic burden of chronic bronchitis in the United States: a retrospective case-control study.
International journal of chronic obstructive pulmonary disease 2011;6():73-81.
2011: Anand A Dalal; Melissa H Roberts; Hans V Petersen; Christopher M Blanchette; Douglas W Mapel
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease 2011;6():13-22.
2010: Bruce Stuart; Linda Jean Simoni-Wastila; Ilene Harris Zuckerman; Amy J Davidoff; Thomas Shaffer; Hui-wen Keri Yang; Jingjing Qian; Anand A Dalal; Douglas W Mapel; Lynda Bryant-Comstock
Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease.
The American journal of geriatric pharmacotherapy 2010;8(5):441-53.
2010: Nicola A Hanania; David M Mannino; Barbara P Yawn; Douglas W Mapel; Fernando J Martinez; James F Donohue; Mark Kosinski; Regina Rendas-Baum; Matthew Mintz; Steven Samuels; Priti Jhingran; Anand A Dalal
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).
Respiratory medicine 2010;104(8):1160-70.
2010: Douglas W Mapel; Hans Petersen; Melissa H Roberts; Judith S Hurley; Floyd J Frost; Jeno P Marton
Can outpatient pharmacy data identify persons with undiagnosed COPD?
The American journal of managed care 2010;16(7):505-12.
2010: Douglas W Mapel
Improved survival in COPD: reasons for hope.
Thorax 2010;65(4):284-5.
2010: Douglas W Mapel; Michael Schum; Eva Lydick; Jeno P Marton
A new method for examining the cost savings of reducing COPD exacerbations.
PharmacoEconomics 2010;28(9):733-49.
2010: Barbara P Yawn; Douglas W Mapel; David M Mannino; Fernando J Martinez; James F Donohue; Nicola A Hanania; Mark Kosinski; Regina Rendas-Baum; Matthew Mintz; Steven Samuels; Anand A Dalal
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.
International journal of chronic obstructive pulmonary disease 2010;5():1-10.
2009: Stephanie R Earnshaw; Michele R Wilson; Anand A Dalal; Mike G Chambers; Priti Jhingran; Richard Stanford; Douglas W Mapel
Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
Respiratory medicine 2009;103(1):12-21.
2008: Mark B Parshall; Douglas W Mapel; Leanne Rice; Angela Williams; John O'Reilly
Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation.
Heart & lung : the journal of critical care 2008;37(5):356-65.
2008: Douglas W Mapel; Scott B Robinson; Eva Lydick
A comparison of health-care costs in patients with chronic obstructive pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems.
Respiratory care 2008;53(9):1169-75.
2008: Marc Decramer; Stephen Rennard; Thierry Troosters; Douglas W Mapel; Nicholas D Giardino; David Mannino; Emiel Wouters; Sanjay Sethi; Christopher B Cooper
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
COPD 2008;5(4):235-56.
2008: Fadia T. Shaya; Du Dongyi; Manabu O Akazawa; Christopher M Blanchette; Jingshu Wang; Douglas W Mapel; Anand Dalal; Steven M Scharf
Burden of concomitant asthma and COPD in a Medicaid population.
Chest 2008;134(1):14-9.
2008: Douglas W Mapel; Scott B Robinson; Homa B Dastani; Hemal Shah; Amy L Phillips; Eva Lydick
The direct medical costs of undiagnosed chronic obstructive pulmonary disease.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(4):628-36.
2007: Douglas W Mapel; Leila S Nelson; Eva Lydick; Joan Soriano; Marianne Ulcickas Yood; Kourtney J Davis
Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
COPD 2007;4(2):127-34.
2006: Douglas W Mapel
Estimating the cost of COPD--a matter of perspective.
COPD 2006;3(4):177-8.
2006: Douglas W Mapel; Floyd J Frost; Judith S Hurley; Hans Petersen; Melissa Roberts; Jeno P Marton; Hemal Shah
An algorithm for the identification of undiagnosed COPD cases using administrative claims data.
Journal of managed care pharmacy : JMCP 2006;12(6):457-65.
2006: Dennis E Doherty; Thomas L Petty; William Bailey; Brian Carlin; Richard Cassaburi; Kent Christopher; Paul A Kvale; Barry Make; Douglas W Mapel; Paul Selecky; Jon Tiger
Recommendations of the 6th long-term oxygen therapy consensus conference.
Respiratory care 2006;51(5):519-25.
2006: Douglas W Mapel; Judith S Hurley; Douglas Roblin; Melissa Roberts; Kourtney J Davis; Robert Schreiner; Floyd J Frost
Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
Respiratory medicine 2006;100(4):595-609.
2006: D M Mannino; G Watt; D Hole; Charles R Gillis; C Hart; Alex McConnachie; G Davey Smith; Mark Upton; Victor M Hawthorne; D D Sin; S F Paul Man; S Van Eeden; Douglas W Mapel; J Vestbo
The natural history of chronic obstructive pulmonary disease.
The European respiratory journal 2006;27(3):627-43.
2005: Yves M Gagnon; Adrian R Levy; Michael D Spencer; Judith S Hurley; Floyd J Frost; Douglas W Mapel; Andrew H Briggs
Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Respiratory medicine 2005;99(12):1534-45.
2005: Douglas W Mapel; Garnett P McMillan; Floyd J Frost; Judith S Hurley; Maria A Picchi; Eva Lydick; Michael D Spencer
Predicting the costs of managing patients with chronic obstructive pulmonary disease.
Respiratory medicine 2005;99(10):1325-33.
2005: Douglas W Mapel; David L Dedrick; Kourtney Davis
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999.
COPD 2005;2(1):35-41.
2004: Douglas W Mapel
Treatment implications on morbidity and mortality in COPD.
Chest 2004;126(2 Suppl):150S-158S; discussion 159S-161S.
2004: Douglas W Mapel; Joyce C Chen; Dorothy George; Ronald Halbert
The cost of chronic obstructive pulmonary disease and its effects on managed care.
Managed care interface 2004;17(4):61-6.
2004: Douglas W Mapel; Michael Shainline; Kathy Paez; Margaret J Gunter
Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.
The Journal of rheumatology 2004;31(3):573-83.
2003: P Burney; S Suissa; joan soriano; William M. Vollmer; G Viegi; S D Sullivan; L M Fabbri; D D Sin; P Ernst; David B Coultas; J Bourbeau; Douglas W Mapel; K Weiss; T McLaughlin; D Price; Miriam C J M Sturkenboom; R Taylor; G W Hagan
The pharmacoepidemiology of COPD: recent advances and methodological discussion.
The European respiratory journal. Supplement 2003;43():1s-44s.
2003: David B Coultas; Douglas W Mapel
Undiagnosed airflow obstruction: prevalence and implications.
Current opinion in pulmonary medicine 2003;9(2):96-103.
2002: David L Dedrick; Lee K Brown; Douglas W Mapel
A 47-year-old woman with wheezing and respiratory failure unresponsive to conventional ventilatory modalities.
Chest 2002;121(5):1688-91.
2001: D B Coultas; Douglas W Mapel; R Gagnon; E Lydick
The health impact of undiagnosed airflow obstruction in a national sample of United States adults.
American journal of respiratory and critical care medicine 2001;164(3):372-7.
2000: Douglas W Mapel; Judith S Hurley; Floyd J Frost; Hans V Petersen; Maria A Picchi; David B Coultas
Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.
Archives of internal medicine 2000;160(17):2653-8.
2000: Douglas W Mapel; Maria A Picchi; Judith S Hurley; Floyd J Frost; Hans V Petersen; V M Mapel; David B Coultas
Utilization in COPD: patient characteristics and diagnostic evaluation.
Chest 2000;117(5 Suppl 2):346S-53S.
1999: R Thomas Temes; M Feteiha; Douglas W Mapel; Richard E Crowell; Loren Ketai; Jorge A Wernly
Esophageal rupture after regional anesthesia: report of two cases.
Journal of clinical gastroenterology 1999;28(4):360-3.
1999: R Thomas Temes; T Chavez; Douglas W Mapel; Loren Ketai; Richard E Crowell; Charles R Key; FM Follis; Stuart Pett; Jorge A Wernly
Primary mediastinal malignancies: findings in 219 patients.
The Western journal of medicine 1999;170(3):161-6.
1998: Douglas W Mapel; William C Hunt; R Utton; Kathy B Baumgartner; Jonathan M Samet; David B Coultas
Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.
Thorax 1998;53(6):469-76.
1998: R Thomas Temes; Richard E Crowell; Douglas W Mapel; Loren Ketai; Stuart Pett; Jorge A Wernly
Mediastinitis without antecedent surgery.
The Thoracic and cardiovascular surgeon 1998;46(2):84-8.
1997: Douglas W Mapel; David B Coultas; D S James; William C Hunt; Christine A Stidley; Frank D Gilliland
Ethnic differences in the prevalence of nonmalignant respiratory disease among uranium miners.
American journal of public health 1997;87(5):833-8.
1996: Douglas W Mapel; Jonathan M Samet; David B Coultas
Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future.
Chest 1996;110(4):1058-67.
1996: Douglas W Mapel; R H Fei; Richard E Crowell
Adenocarcinoma of the lung presenting as a diffuse interstitial process in a 25-year-old man.
Lung cancer (Amsterdam, Netherlands) 1996;15(2):239-44.